Engelmann K, Valtink M, Lindemann D, Nitschke M
Augenklinik, Klinikum Chemnitz gGmbH, Flemmingstrasse 2, Chemnitz.
Klin Monbl Augenheilkd. 2011 Aug;228(8):712-23. doi: 10.1055/s-0029-1245868. Epub 2011 Mar 23.
Endothelial keratoplasty is a promising surgical procedure which may replace penetrating keratoplasty in cases of endothelial cell diseases of the cornea. This method may thereby help to prevent postoperative astigmatism and transplant rejection.
A survey of publications reporting about results after endothelial keratoplasty shows that the main problem of this transplantation technique is a postoperative endothelial cell loss which is comparable to or even higher than that observed in penetrating keratoplasty. Improving surgical techniques led to a reduction of the endothelial cell loss, however, cell-based strategies to prevent postoperative cell loss or to enhance the cell densities of donor corneas or endothelial lamellae are rare.
This review presents an overview of clinical results after endothelial keratoplasty. Current strategies in the field of cell biology and tissue cultivation of corneal endothelial cells, genetic manipulation of the corneal endothelium and tissue engineering strategies aiming at the production of transplantable endothelial cell sheets are described.
The limited availability of donor corneas makes it mandatory to develop methods in the field of tissue engineering in order to improve corneal endothelial cell survival or to increase corneal endothelial cell density, using interdisciplinary approaches.
内皮角膜移植术是一种很有前景的外科手术,在角膜内皮细胞疾病的病例中,它可能会取代穿透性角膜移植术。该方法因此可能有助于预防术后散光和移植排斥反应。
一项关于内皮角膜移植术后结果的出版物调查显示,这种移植技术的主要问题是术后内皮细胞丢失,其与穿透性角膜移植术中观察到的情况相当甚至更高。手术技术的改进导致了内皮细胞丢失的减少,然而,基于细胞的预防术后细胞丢失或提高供体角膜或内皮薄片细胞密度的策略却很少见。
本综述概述了内皮角膜移植术后的临床结果。描述了角膜内皮细胞的细胞生物学和组织培养领域的当前策略、角膜内皮的基因操作以及旨在生产可移植内皮细胞片的组织工程策略。
供体角膜的有限可用性使得必须采用跨学科方法在组织工程领域开发方法,以提高角膜内皮细胞的存活率或增加角膜内皮细胞密度。